Internal Medicine, Medical Oncology · New York, NY
NPI
1144696485
Since 2015
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
300 E 66th St, 1405
New York, NY, 10065
Phone (646) 888-4630
Groups this clinician bills Medicare through
Medicare paid, 2024
$72K
714 services
Medicare patients, 2024
168
Average age 73
Drug cost, 2024
$2.2M
534 prescriptions
Company payments, 2025
$17K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ciara M Kelly was code 99214 (office e&m - established), 293 times for 102 patients. In total Ciara M Kelly billed 714 services in 12 codes, and Medicare paid $72K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-08-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 293 | 102 | $88.13 | $26K |
| 99215 Office E&M - Established | Office | 237 | 90 | $132.32 | $31K |
| 99213 Office E&M - Established | Office | 78 | 50 | $59.64 | $4,652 |
| 99205 Office E&M - New | Office | 35 | 35 | $159.79 | $5,593 |
| 99442 Telephone Services | Office | 20 | 19 | $66.96 | $1,339 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 17 | 13 | $14.22 | $242 |
By year: 2022 $51K for 583 services; 2023 $49K for 527 services; 2024 $72K for 714 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ciara M Kelly prescribed most often to Medicare patients was Imatinib Mesylate, with 109 prescriptions and refills. In total Ciara M Kelly wrote 534 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 109 | 129 | 19 | $327K |
| Pantoprazole Sodium Generic | 33 | 51 | 11 | $201 |
| Levothyroxine Sodium Generic | 28 | 32 | Under 11 | $246 |
| Prednisone Generic | 20 | 23 | 12 | $61.97 |
| Ondansetron Odt Ondansetron | 19 | 21 | 13 | $1,241 |
| Atorvastatin Calcium Generic | 18 | 20 | Under 11 | $83.68 |
| Sunitinib Malate Generic | 16 | 16 | Under 11 | $109K |
| Mounjaro Tirzepatide | 16 | 32 | Under 11 | $34K |
| Qinlock Ripretinib | 14 | 14 | Under 11 | $1.1M |
| Gabapentin Generic | 14 | 14 | Under 11 | $69.99 |
| Ondansetron Hcl Generic | 14 | 14 | Under 11 | $154 |
| Cabometyx Cabozantinib S-Malate | 13 | 13 | Under 11 | $303K |
| Dexamethasone Generic | 13 | 15 | 11 | $296 |
| Prochlorperazine Maleate Generic | 12 | 12 | Under 11 | $253 |
| Triamcinolone Acetonide Generic | 11 | 11 | Under 11 | $39.56 |
Brand drugs: 95 claims; generic drugs: 439 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ciara M Kelly $17K ($17K in general payments such as food, travel and fees) from 4 companies. The largest payer was Deciphera Pharmaceuticals Inc. with $17K.
| Company | Payments | Amount |
|---|---|---|
| Deciphera Pharmaceuticals Inc. | 14 | $17K |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.